Is Perfect the Enemy of Good? Weighing the Evidence for Biparametric MRI in Prostate Cancer

Citation:

Cole AP, Langbein BJ, Giganti F, Fennessy FM, Tempany CM, Emberton M. Is Perfect the Enemy of Good? Weighing the Evidence for Biparametric MRI in Prostate Cancer. Br J Radiol. 2022;95 (1131) :20210840. Copy at http://www.tinyurl.com/y5hxnjxe

Date Published:

2022 Mar 01

Abstract:

The role of multiparametric MRI in diagnosis, staging and treatment planning for prostate cancer is well established. However, there remain several challenges to widespread adoption. One such challenge is the duration and cost of the examination. Abbreviated exams omitting contrast-enhanced sequences may help address this challenge. In this review, we will discuss the rationale for biparametric MRI for detection and characterization of clinically significant prostate cancer prior to biopsy and synthesize the published literature. We will weigh up the advantages and disadvantages to this approach and lay out a conceptual cost/benefit analysis regarding adoption of biparametric MRI.

Last updated on 04/15/2022